Qube Research & Technologies (QRT)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Qube Research & Technologies (QRT)'s NVCR Position: Q3 2026 in Review
Qube Research & Technologies (QRT) increased its NovoCure (NVCR) stake by 52% in Q3 2026, buying an estimated $5.26M and bringing the position to 920,744 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #1205.
Qube Research & Technologies (QRT) first reported a position in NVCR in Q1 2020 and has held it in 18 quarters since. The position peaked at $25.3M in Q2 2021. 242 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- Qube Research & Technologies (QRT) held 920,744 shares of NovoCure worth $14.7M as of Q3 2026.
- Qube Research & Technologies (QRT) bought 314,870 NovoCure shares in Q3 2026, an estimated $5.26M.
- NovoCure made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1205 holding.
- Qube Research & Technologies (QRT) first reported a position in NovoCure in Q1 2020 and has held it in 18 quarters since.
- Qube Research & Technologies (QRT)'s NovoCure position peaked at $25.3M in Q2 2021.
- 242 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.